TLIS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Stats
Today's Volume	7 581.00
Average Volume	8 990.00
Market Cap	16.37M
EPS	$0 ( 2024-03-27 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.260
ATR14	$0.0740 (0.82%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-01	Lukowiak Andrew A	Buy	30 575	Stock option (right to buy)
2023-08-01	Lukowiak Andrew A	Buy	0
2023-07-17	Markovich Rebecca	Buy	13 071	Stock option (right to buy)
2023-06-09	Baker Bros. Advisors Lp	Buy	23 685	Non- Qualified Stock Option (right to buy)
2023-06-09	Scott Randal W.	Buy	95 000	Stock option (right to buy)

INSIDER POWER
80.81
Last 91 transactions
Buy: 54 998 856 \| Sell: 42 065 023

Talis Biomedical Correlation

10 Most Positive Correlations
PAIC	0.926
SVAC	0.922
SVOK	0.891
MTSL	0.889
NSTS	0.859
TLGT	0.855
MOGO	0.851
GOODM	0.85
SKYX	0.844
KZIA	0.84

10 Most Negative Correlations
AMRB	-0.929
NETE	-0.923
RAVN	-0.901
MMAC	-0.878
SRAC	-0.868
LWAC	-0.836
LMRKN	-0.807

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Talis Biomedical Financials

Annual	2023
Revenue:	$412 000
Gross Profit:	$-4.70M (-1 141.50 %)
EPS:	$-34.12

Q4	2023
Revenue:	$151 000
Gross Profit:	$-471 000 (-311.92 %)
EPS:	$-0.420

Q3	2023
Revenue:	$76 000.00
Gross Profit:	$70 000.00 (92.11 %)
EPS:	$-8.62

Q2	2023
Revenue:	$48 000.00
Gross Profit:	$41 000.00 (85.42 %)
EPS:	$-8.27

Financial Reports:

No articles found.

Talis Biomedical

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.